Table 2 |
|||
|
Summary of diseases developed in BCR-ABL-GFP and BCR-ABL-GFP + N17 H-Ras mice |
|||
|
Mice |
CML |
B-lymphoid leukemia/lymphoma |
ND* |
|
|
|||
|
BCR-ABL-GFP |
7/7 |
0/7 |
- |
|
BCR-ABL-GFP+ N17 H-Ras |
2/12 |
8/12 |
2/12 |
|
|
|||
|
* Not determined. |
|||
|
Baum and Ren Journal of Hematology & Oncology 2008 1:5 doi:10.1186/1756-8722-1-5 |
|||
